Detection of Metronidazole Resistance in Trichomonas Vaginalis Using Uncultured Vaginal Swabs

Overview

Journal Parasitol Res

Specialty Parasitology

Date 2022 Jun 3

PMID 35657426

Authors

Bongekile Ngobese

Ravesh Singh

Khine Swe Swe- Han

Partson Tinarwo

Nonkululeko Mabaso

Nathlee S Abbai

Affiliations

Soon will be listed here.

Abstract

Trichomonas vaginalis (T. vaginalis) is the most prevalent sexually transmitted infection (STI) globally. Metronidazole is the drug of choice for treating T. vaginalis infections although metronidazole-resistant T. vaginalis has been reported in clinical isolates. The purpose of this study was to determine the presence of mutations in nitroreductase genes associated with metronidazole resistance in vaginal swabs testing positive for T. vaginalis. This study included 385 human immunodeficiency virus (HIV)-positive pregnant women. Vaginal swabs were collected from consenting pregnant women and used for the detection of T. vaginalis using the TaqMan assay. From the vaginal swabs, nitroreductase genes ntr4 and ntr6 containing mutations associated with metronidazole resistance were amplified using a quantitative polymerase chain reaction (PCR) assay. To validate the PCR assay, T. vaginalis cultured isolates with known metronidazole resistance profiles were used as controls in the mutation detection assays. The prevalence of T. vaginalis in the study population was 12.2% (47/385). Mutations associated with resistance to metronidazole were detected in more than 40% of the samples tested, i.e. 21/47 (45%) and 24/47 (51%) for ntr4 and ntr6, respectively. A total of 19 samples (40%) carried mutations for both ntr4 and ntr6 genes associated with metronidazole resistance. The validation assays showed a positive correlation between phenotypic and genotypic resistance profiles. This study found a high prevalence of mutations associated with metronidazole resistance. This is concerning since metronidazole is currently used in the syndromic management of STIs in South Africa. Molecular-based assays for monitoring metronidazole resistance profiles using nitroreductase genes may serve as a feasible method for antimicrobial surveillance studies for T. vaginalis.

Citing Articles

High frequency of point mutations in the nitroreductase 4 and 6 genes of Trichomonas vaginalis associated with metronidazole resistance.

Iturrieta-Gonzalez I, Olivares-Ferretti P, Hidalgo A, Zambrano F, Ossa X, Fonseca-Salamanca F Folia Parasitol (Praha). 2024; 71.

PMID: 39584737 DOI: 10.14411/fp.2024.021.

A novel fluorescent traceable carbon quantum dots with selective antibacterial activity against .

Wang J, Wang Y, Zhang H, Zhu W, Liu L Exp Biol Med (Maywood). 2023; 248(23):2227-2236.

PMID: 38073544 PMC: 10903257. DOI: 10.1177/15353702231211867.

A fluorescence-based assay for Trichomonas vaginalis drug screening.

Chen Q, Li J, Wang Z, Meng W, Wang H, Wang Z Parasit Vectors. 2023; 16(1):329.

PMID: 37723582 PMC: 10507874. DOI: 10.1186/s13071-023-05919-6.

Prevalence and metronidazole resistance of among Japanese women in 2021.

Saito-Nakano Y, Umeki Y, Shimokawa C, Kobayashi K, Hashimoto K, Takada T IJID Reg. 2023; 7:130-135.

PMID: 37025347 PMC: 10070129. DOI: 10.1016/j.ijregi.2023.02.007.

References

Abdel-Magied A, El-Kholya E, Abou El-Khair S, Abdelmegeed E, Hamoudaa M, Mohamed S . The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population. Parasitol Res. 2017; 116(11):3125-3130. DOI: 10.1007/s00436-017-5627-3. View

Abdel-Magied A, Hammouda M, Mosbah A, El-Henawy A . In vitro activity of nitazoxanide against some metronidazole-resistant and susceptible Trichomonas vaginalis isolates. J Infect Chemother. 2017; 23(4):230-233. DOI: 10.1016/j.jiac.2016.12.014. View

Bosserman E, Helms D, Mosure D, Evan Secor W, Workowski K . Utility of antimicrobial susceptibility testing in Trichomonas vaginalis-infected women with clinical treatment failure. Sex Transm Dis. 2011; 38(10):983-7. DOI: 10.1097/OLQ.0b013e318224db39. View

Bouchemal K, Bories C, Loiseau P . Strategies for Prevention and Treatment of Trichomonas vaginalis Infections. Clin Microbiol Rev. 2017; 30(3):811-825. PMC: 5475227. DOI: 10.1128/CMR.00109-16. View

Bradic M, Warring S, Tooley G, Scheid P, Secor W, Land K . Genetic Indicators of Drug Resistance in the Highly Repetitive Genome of Trichomonas vaginalis. Genome Biol Evol. 2017; 9(6):1658-1672. PMC: 5522705. DOI: 10.1093/gbe/evx110. View

Pinheiro Bruni M, da Silveira M, Stauffert D, Bicca G, Dos Santos C, Farias N . Aptima assay elucidates significant underdiagnosis of trichomoniasis among women in Brazil according to an observational study. Sex Transm Infect. 2018; 95(2):129-132. DOI: 10.1136/sextrans-2018-053635. View

Dessai F, Nyirenda M, Sebitloane M, Abbai N . Diagnostic evaluation of the BD Affirm VPIII assay as a point-of-care test for the diagnosis of bacterial vaginosis, trichomoniasis and candidiasis. Int J STD AIDS. 2020; 31(4):303-311. DOI: 10.1177/0956462419895684. View

Ertabaklar H, Yaman Karadam S, Malatyali E, Ertug S . [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis]. Mikrobiyol Bul. 2017; 50(4):552-558. DOI: 10.5578/mb.30140. View

Ginocchio C, Chapin K, Smith J, Aslanzadeh J, Snook J, Hill C . Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay. J Clin Microbiol. 2012; 50(8):2601-8. PMC: 3421522. DOI: 10.1128/JCM.00748-12. View

10.

M Hussien E, El-Sayed H, Shaban M, Salm A, Rashwan M . Biological variability of Trichomonas vaginalis clinical isolates from symptomatic and asymptomatic patients. J Egypt Soc Parasitol. 2004; 34(3):979-88. View

11.

Davey D, Peters R, Kojima N, Mudau M, de Vos L, Olivier D . Sexual Behaviors of Human Immunodeficiency Virus-Infected Pregnant Women and Factors Associated With Sexually Transmitted Infection in South Africa. Sex Transm Dis. 2018; 45(11):754-761. PMC: 6173658. DOI: 10.1097/OLQ.0000000000000847. View

12.

Davey D, Nyemba D, Gomba Y, Bekker L, Taleghani S, DiTullio D . Prevalence and correlates of sexually transmitted infections in pregnancy in HIV-infected and- uninfected women in Cape Town, South Africa. PLoS One. 2019; 14(7):e0218349. PMC: 6602171. DOI: 10.1371/journal.pone.0218349. View

13.

Kirkcaldy R, Augostini P, Asbel L, Bernstein K, Kerani R, Mettenbrink C . Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD Surveillance Network, 2009-2010. Emerg Infect Dis. 2012; 18(6):939-43. PMC: 3358158. DOI: 10.3201/eid1806.111590. View

14.

Kissinger P . Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues. BMC Infect Dis. 2015; 15:307. PMC: 4525749. DOI: 10.1186/s12879-015-1055-0. View

15.

Kissinger P, Muzny C, Mena L, Lillis R, Schwebke J, Beauchamps L . Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial. Lancet Infect Dis. 2018; 18(11):1251-1259. PMC: 6279510. DOI: 10.1016/S1473-3099(18)30423-7. View

16.

Krashin J, Koumans E, Bradshaw-Sydnor A, Braxton J, Evan Secor W, Sawyer M . Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population. Sex Transm Dis. 2010; 37(7):440-4. DOI: 10.1097/OLQ.0b013e3181cfcd8c. View

17.

Kulda J . Trichomonads, hydrogenosomes and drug resistance. Int J Parasitol. 1999; 29(2):199-212. DOI: 10.1016/s0020-7519(98)00155-6. View

18.

Land K, Clemens D, Johnson P . Loss of multiple hydrogenosomal proteins associated with organelle metabolism and high-level drug resistance in trichomonads. Exp Parasitol. 2001; 97(2):102-10. DOI: 10.1006/expr.2001.4587. View

19.

Leitsch D, Janssen B, Kolarich D, Johnson P, Duchene M . Trichomonas vaginalis flavin reductase 1 and its role in metronidazole resistance. Mol Microbiol. 2013; 91(1):198-208. PMC: 4437529. DOI: 10.1111/mmi.12455. View

20.

Mabaso N, Abbai N . Distribution of genotypes in relation to metronidazole susceptibility patterns in Trichomonas vaginalis isolated from South African pregnant women. Parasitol Res. 2021; 120(6):2233-2241. PMC: 8128682. DOI: 10.1007/s00436-021-07177-w. View